Novel Functional Assay Approaches for GPCR Ligand Discovery. Comparison of three different technologies to assess slow acting agonist activity. FLIPR, CellKey and IP-One HTRF

Bouhelal R

2007

Novartis Institutes for Biomedical Research, Basel, Switzerland

Screening Europe 2007, Barcelona, Spain

Comparison of three different technologies to assess slow acting agonist activity. FLIPR™, CellKey™ and IP-One HTRF®.

GPCR research from A to Z